ISMRM 21st Annual Meeting & Exhibition 20-26 April 2013 Salt Lake City, Utah, USA

Clinical Cancer MRI - Cased-Based Teaching
SKILL LEVEL: Basic to Intermediate
ORGANIZERS: Elizabeth A. Morris, M.D., F.A.C.R. & Evis Sala, M.D., Ph.D.
Sunday, 20 April 2013
This one-day course focuses on the added clinical value of evolving MRI technology The program will address in detail via didactic-interactive lectures using the audience response technology the current state-of-art MRI protocols with application in breast, prostate, small bowel and gynecological imaging. The course is patient focused, comparative (the MRI being compared with other imaging modalities) and appraises the potential impact of MRI in individualized patient care.
This course is aimed at radiologists, MR technologists and clinical support scientists who wish to incorporate the use of MR into their practice and to know how evolving MRI techniques can aid in clinical problem-solving in the body, and impact individualized patient care.

Upon completion of this course, participants should be able to:

  • Describe common clinical problem at a variety of anatomic sites, at various stages of a cancer patient's journey;
  • Explain how technological advances and understanding of tumor biology can help address challenges in cancer diagnosis and therapy assessment;
  • Compare and explain the relative merits and limitations of imaging versus other methods in addressing clinical needs; and
  • Appreciate where further scientific/technical developments are needed so as to advance patient care at the point of delivery.


Moderators: Fiona J. Gilbert, M.D. & Elizabeth A. Morris, M.D., F.A.C.R.

      Cancer Detection Issues  
08:30   Finding Cancer in the Dense Breast: What Can MRI Add? Fiona J. Gilbert, M.D.
09:00 Rising PSA: Is There A Cancer? Jurgen J. Fütterer, M.D., Ph.D.
09:30 Cirrhotic Liver: What Is That Nodule? Claude B. Sirlin, M.D.
10:00     Break - Meet the Teachers  
      Characterization of Incidental Lesions  
10:30 Characterization of Cystic Abdominal Lesions Jay P. Heiken, M.D.
11:00 Liver Lesions in Cancer Patients: What Are They? Jeong Min Lee, M.D.
11:30 Incidental Adnexal Masses in Cancer Patients: Act, Ignore or Follow? Elizabeth A. Sadowski, M.D.
12:00     Break  
      12:00-12:15 Meet the Teachers  
      Response to Therapy  
13:30 Breast Cancer Response to NAC: How Reliable Is It? Nola M. Hylton, Ph.D.
14:00 Bone Metastases Response to Therapy: MRI versus Nuc Med Christina Messiou, M.D., F.R.C.R.
14:30 Measuring Response to Novel Therapies: Thinking Differently Mark A. Rosen, M.D., Ph.D.
15:00     Break - Meet the Teachers  
      Residual Disease versus Recurrence  
15:30 Rising PSA in the Treated Prostate Gland Aytekin Oto, M.D.
16:00 Pain in the Treated Pelvis Yuliya Lakhman, M.D.
16:30 The Role of Biological MR Imaging in the Treatment of Head & Neck Cancer Suresh Mukherji, M.D.
17:00     Adjournment  
      17:00-17:15 Meet the Teachers